[…] lymph node affected by Hodgkin’s lymphoma, a cancer of lymphoma white blood cells. Stock image. Tumour immunology encompasses the study of interactions between tumours and the immune system, focusing on […]
Tumour immunology studies the complex interactions between cancer cells and the immune system. Research in this field aims to uncover the mechanisms by which the immune system inhibits cancer […]
CancerTools.org is committed to empower cancer researchers and the advancement of novel discoveries in tumour immunology by providing relevant research tools, including antibodies targeting tumour antigens. Image: Human breast cancer […]
[…] patients with advanced disease is still below 20%1. Lung cancer models that more accurately reflect tumour heterogeneity, disease progression and mimic patient responses, are needed to aid effective cancer research […]
[…] models to enhance preclinical drug discovery workflows, as well as widely used antibodies to study tumour signalling pathways. CancerTools.org provides diverse breast cancer cell lines to accurately model the tumour-microenvironment, […]
[…] recognises an epitope at aa 211-217 in the DNA binding region of p53. Alternative p53 antibodies that also detect mutant p53 include DO-11 (Cat. #153402) and DO-12 (Cat. #153403). To […]
Anti p53 monoclonal antibody used to analyse and detect the most mutated gene in cancer’ p53 and its protein interactions, enabling identification of transformed cell lines.
Tumor necrosis factor is a cell signaling protein or cytokine that is involved in inflammation, and specifically one of the proteins in the acute phase reaction.
Anti-p53 DO-11 antibody recognises the human cellular tumour antigen p53, also known as p53 tumour suppressor protein or NY-CO-13. p53 is a 393 amino acid ~53kDa cytoplasmic/ nuclear protein upregulated […]
[…] microenvironment or genetic changes, is known to have an important role in the growth of experimental tumours. HIF1A has been observed in varying subsets of tumour cells from various solid tumours.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.
